Warner Carr

Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

Jean Bousquet, Holger J. Schünemann, Bolesław Samoliński et al. · Journal of Allergy and Clinical Immunology · 2012 · 639 citations · Full text

Life Sciences, Immunology, Otolaryngology +14

A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis

Warner Carr, Jonathan A. Bernstein, Phil Lieberman et al. · Journal of Allergy and Clinical Immunology · 2012 · 239 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial

John A. Smith, Michael M. Kitt, Alyn H. Morice et al. · The Lancet Respiratory Medicine · 2020 · 224 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

Clinically Relevant Effect of a New Intranasal Therapy (MP29-02) in Allergic Rhinitis Assessed by Responder Analysis

Eli O. Meltzer, Paul H. Ratner, Claus Bachert et al. · International Archives of Allergy and Immunology · 2013 · 117 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled trial of efficacy and safety

Eli O. Meltzer, Craig LaForce, Paul H. Ratner et al. · Allergy and Asthma Proceedings · 2012 · 100 citations

Pharmacy, Pharmacology, Pharmacotherapy +17